Recital 15, Regulation (EU) 2024/2052

In forcesince 30 Jul 2024

Currently. the calculation of the detection capability for screening (CCβ) for Method 2 for unauthorised or prohibited pharmacologically active substances includes only the cases where the chosen screening target concentration provides less than or equal to 5 % false compliant results. Therefore, a provision for the case where the percentage of false compliant results is higher than 5 should be added.